carbostyril has been researched along with Ovarian Neoplasms in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 3 (33.33) | 2.80 |
Authors | Studies |
---|---|
Gong, L; Han, S; He, C; Lei, Y; Luo, Z; Ma, J; Tan, X; Tang, H; Xie, L | 1 |
Kwon, M; Lee, DW; Lee, HN; Lee, W | 1 |
Chan, HC; Chang, HW; Liao, YH; Liu, CH | 1 |
Bjarnason, GA; Edeline, J; Escudier, B; Faivre, S; Fartoux, L; Germann, N; Hirte, H; Jones, R; Mackay, H; Oza, A; Plummer, R; Pouget, JC; Thistlethwaite, F; Van Cutsem, E; Vergote, I | 1 |
Fujiwara, K; Hasegawa, K; Ikeda, Y; Imai, Y; Iwasa, A; Kato, T; Miyamoto, T; Nakamura, Y; Okabe, S; Park, JH; Takamatsu, N | 1 |
Adachi, K; Eguchi, S; Fujii, T; Fujimoto, A; Inoue, T; Kawana, K; Nagamatsu, T; Nakamura, H; Nishida, H; Oda, K; Ogishima, J; Osuga, Y; Sato, M; Taguchi, A; Tomio, K; Wada-Hiraike, O; Yamashita, A; Yoshida, M | 1 |
Chen, T; Ge, S; Guo, H; Hu, P; Li, X; Liu, Y; Nadkarni, DH; Velu, SE; Wang, H; Wang, W; Xu, Y; Yang, X; Zhang, R | 1 |
Chou, LC; Chung, JG; Huang, CH; Huang, LJ; Hung, MC; Kuo, SC; Lee, JC; Lee, KH; Way, TD | 1 |
Anderson, E; Bundred, NJ; Clarke, RB; Knox, F; Morris, J; Wärnberg, F; White, D | 1 |
1 trial(s) available for carbostyril and Ovarian Neoplasms
Article | Year |
---|---|
A Phase II Multicentre, Open-Label, Proof-of-Concept Study of Tasquinimod in Hepatocellular, Ovarian, Renal Cell, and Gastric Cancers.
Topics: Antineoplastic Agents; Carcinoma; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Kidney Neoplasms; Liver Neoplasms; Male; Ovarian Neoplasms; Quinolones; Stomach Neoplasms | 2017 |
8 other study(ies) available for carbostyril and Ovarian Neoplasms
Article | Year |
---|---|
Integrative, genome-wide association study identifies chemicals associated with common women's malignancies.
Topics: Breast Neoplasms; Environmental Exposure; Female; Fenofibrate; Gene Expression Profiling; Genome-Wide Association Study; Glafenine; Humans; Incidence; Methylnitronitrosoguanidine; Ovarian Neoplasms; Parabens; Phenols; Quinolones; Uterine Cervical Neoplasms | 2020 |
Dual inhibition of FOXM1 and its compensatory signaling pathway decreased the survival of ovarian cancer cells.
Topics: Acetophenones; Benzopyrans; Cell Line, Tumor; Cell Survival; Female; Forkhead Box Protein M1; GTP Phosphohydrolases; Humans; Membrane Proteins; Ovarian Neoplasms; Pyridines; Quinazolines; Quinolones; Signal Transduction; Thiophenes | 2021 |
The mechanism of anticancer activity of the new synthesized compound - 6,7-Methylenedioxy-4-(2,4-dimethoxyphenyl)quinolin -2(1H)-one(12e) in human ovarian cancer cell lines.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Female; Humans; Ovarian Neoplasms; Ovary; Quinolones | 2021 |
T-LAK Cell-Originated Protein Kinase (TOPK) as a Prognostic Factor and a Potential Therapeutic Target in Ovarian Cancer.
Topics: Animals; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Disease-Free Survival; Female; Forkhead Box Protein M1; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mitogen-Activated Protein Kinase Kinases; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Prognosis; Protein Kinase Inhibitors; Quinolones; Thiophenes | 2016 |
Targeting glutamine metabolism and the focal adhesion kinase additively inhibits the mammalian target of the rapamycin pathway in spheroid cancer stem-like properties of ovarian clear cell carcinoma in vitro.
Topics: Adenocarcinoma, Clear Cell; Aminooxyacetic Acid; Cell Culture Techniques; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Therapy, Combination; Enzyme Inhibitors; Female; Focal Adhesion Kinase 1; Glutamine; Humans; Ovarian Neoplasms; Phosphorylation; Quinolones; RNA, Messenger; Sequence Analysis, RNA; Signal Transduction; Spheroids, Cellular; Sulfones; TOR Serine-Threonine Kinases; Transaminases | 2017 |
Experimental therapy of ovarian cancer with synthetic makaluvamine analog: in vitro and in vivo anticancer activity and molecular mechanisms of action.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Humans; Membrane Potential, Mitochondrial; Mice; Ovarian Neoplasms; Pyrroles; Quinolones; Signal Transduction; Xenograft Model Antitumor Assays | 2011 |
CHM-1 induces apoptosis via p38-mediated upregulation of DR5 expression in human ovarian cancer SKOV3 cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 8; Cell Line, Tumor; Cell Proliferation; Dioxoles; Female; Gene Expression Regulation, Neoplastic; Humans; Hydrophobic and Hydrophilic Interactions; Mice; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Quinolines; Quinolones; Receptors, TNF-Related Apoptosis-Inducing Ligand; Signal Transduction; Survival Analysis; Up-Regulation; Xenograft Model Antitumor Assays | 2011 |
Effect of a farnesyl transferase inhibitor (R115777) on ductal carcinoma in situ of the breast in a human xenograft model and on breast and ovarian cancer cell growth in vitro and in vivo.
Topics: Animals; Breast Neoplasms; Calcinosis; Carcinoma, Intraductal, Noninfiltrating; Cell Division; Cell Line, Tumor; Farnesyltranstransferase; Female; Humans; Mammography; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Quinolones; Transplantation, Heterologous | 2006 |